Public

American Hospital Association content that is available to the public and all website users.

While the AHA strongly supports CMS’ goal of modernizing prior authorization and extending interoperability requirements, the effectiveness of these policies will depend on thoughtful implementation that aligns with clinical workflows, ensures consistent payer behavior and meaningfully reduces…
Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients by providing 340B drug pricing discounts and expand health services to the patients and…
AHA members are pursuing practices that can reduce health outcome disparities and thereby improve health outcomes for all populations.
Budget reconciliation is an optional process under the Congressional Budget Act of 1974 that allows for expedited consideration of certain fiscal legislation that makes changes to mandatory spending, revenues and/or the debt limit.
AHA Comments on the Advancing Interoperability and Improving Prior Authorization Processes Proposed Rule
AHA Today is a newsletter that brings you a roundup of news and resources from the AHA. Subscribe today!
The AHA Board of Trustees created the Task Force on Ensuring Access in Vulnerable Communities. Comprised of 29 hospital and health system leaders and state hospital association CEOs, the task force held meetings, heard from policymakers and conducted field hearings to speak with hospital and…
A UVA Health scientist has developed an experimental drug that reversed paralysis and vision loss in a laboratory mouse model of multiple sclerosis (MS), offering a potential new therapy for a disease that currently has no cure.
The Wound Care Center at Harrington at Charlton, part of UMass Memorial Health, offers hyperbaric oxygen therapy to treat complex wounds such as severe diabetic foot ulcers, burns, gangrene, and infections of tissues or bone that cause tissue death.
On November 4, 2026, reports on the alleged attack on the French Blood Establishment (EFS) started circulating in French news outlets.